Country: United States
Language: English
Source: NLM (National Library of Medicine)
KETOCONAZOLE (UNII: R9400W927I) (KETOCONAZOLE - UNII:R9400W927I)
Tasman Pharma Inc.
TOPICAL
PRESCRIPTION DRUG
Ketoconazole cream, 2%is indicated for the topical treatment of tinea corporis, tinea cruris and tinea pedis caused by Trichophyton rubrum , T. mentagrophytes and Epidermophyton floccosum ; in the treatment of tinea (pityriasis) versicolor caused by Malassezia furfur (Pityrosporum orbiculare) ; in the treatment of cutaneous candidiasis caused by Candida spp. and in treatment of seborrheic dermatitis. Ketoconazole cream, 2% is contraindicated in persons who have shown hypersensitivity to the active or excipient ingredients of this formulation.
Ketoconazole cream, 2% is supplied in 15 (NDC 72641-005-15), 30 (NDC 72641-005-30), and 60 (NDC 72641-005-60) gram tubes. Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F.) [see USP Controlled Room Temperature]. Manufactured For: Tasman Pharma Inc. Warminster, PA 18974 Made in Canada Rev. 07/2021
Abbreviated New Drug Application
KETOCONAZOLE CREAM, 2%- KETOCONAZOLE CREAM, 2% CREAM TASMAN PHARMA INC. ---------- KETOCONAZOLE CREAM, 2% DESCRIPTION Ketoconazole cream, 2% contains the broad-spectrum synthetic antifungal agent, ketoconazole 2%, formulated in an aqueous cream vehicle consisting of propylene glycol, stearyl and cetyl alcohols, sorbitan monostearate, polysorbate 60, isopropyl myristate, butylated hydroxyanisole, polysorbate 80 and purified water. Ketoconazole is _cis_-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1_H_-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]methoxy]phenyl]piperazine and has the following structural formula: Molecular Formula: C H Cl N O Molecular Weight: 531.44 CLINICAL PHARMACOLOGY When ketoconazole cream, 2% was applied dermally to intact or abraded skin of Beagle dogs for 28 consecutive days at a dose of 80 mg, there were no detectable plasma levels using an assay method having a lower detection limit of 2 ng/ml. After a single topical application to the chest, back and arms of normal volunteers, systemic absorption of ketoconazole was not detected at the 5 ng/ml level in blood over a 72-hour period. Two dermal irritancy studies, a human sensitization test, a phototoxicity study and a photoallergy study conducted in 38 male and 62 female volunteers showed no contact sensitization of the delayed hypersensitivity type, no irritation, no phototoxicity and no photoallergenic potential due to ketoconazole cream, 2%. 26 28 2 4 4 MICROBIOLOGY Ketaconozole is a boad spectrum synthetic anti-fungal agent which inhibits the _in vitro_ growth of the following common dermatophytes and yeasts by altering the permeability of the cell membrane: dermatophytes: _Trichophyton rubrum, T. mentagrophytes, T._ _tonsurans, Microsporum canis, M. audouini, M. gypseum_ and _Epidermophyton_ _floccosum;_ yeasts: _Candida albicans, Malassezia ovale (Pityrosporum ovale) _and_ C._ _tropicalis;_ and the organism responsible for tinea versicolor, _Malassezia furfur_ _(Pityrosporum orbiculare)._ Only those organisms listed in the INDICATIONS AND US Read the complete document